title: Impact of prophylactic measures on prevalence of anti HCV and viral genotypes in a dialysis unit.
authors.forename: J
authors.initials: J
authors.lastname: Morales
authors.forename: C
authors.initials: C
authors.lastname: Durán
authors.forename: G
authors.initials: G
authors.lastname: Artigas
authors.forename: G
authors.initials: G
authors.lastname: Muñoz
authors.forename: A
authors.initials: A
authors.lastname: Fierro
authors.forename: A
authors.initials: A
authors.lastname: Vukusich
authors.forename: J
authors.initials: J
authors.lastname: Mañalich
authors.forename: J
authors.initials: J
authors.lastname: Brahm
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D005260:Female; D005838:Genotype; D006526:Hepatitis C / Q000235:genetics* / Q000517:prevention & control*; D018937:Hepatitis C Antibodies / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011315:Preventive Medicine / Q000379:methods; D006435:Renal Dialysis / Q000379:methods*
chemical_list: D018937:Hepatitis C Antibodies